CLINICAL_TRIALS
research
· 2012-04-11
Clinical Trial Update: Temsirolimus-RCC-imaging [Phase 2]
Summary
Phase 2 clinical trial update on temsirolimus for renal cell carcinoma with an imaging focus; current trial status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radboud University Medical Center | Conditions: Renal Cell Cancer | Phase 2 | Status: UNKNOWN